Carbetocin to reduce bleeding during fibroid removal surgery
Treatments studied
Part of Blood & lymphatic, Women’s health & pregnancy clinical trials.
This trial tests if a drug called carbetocin (which helps the uterus contract) can reduce bleeding during myomectomy surgery for fibroids. If you are having an open myomectomy, this study may help lower your risk of heavy blood loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to have a myomectomy (surgery to remove fibroids).
- Your surgery type is an open abdominal myomectomy (incision in the belly).
- You are not allergic to carbetocin or similar medications.
- You do not have a history of blood clots, bleeding disorders, kidney or liver disease, or chronic anemia.
- You have not had prior procedures to shrink fibroids (like embolization or GnRH analogue therapy) before this surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
This trial compares two medications (ergometrine and carbetocin) given during surgery to see which one is better at reducing bleeding while removing fibroids. Both drugs help the uterus contract to control blood loss.
This trial compares two injected medicines (terlipressin vs carbetocin) given into the uterus during open fibroid (myomectomy) surgery to see which one reduces blood loss and helps maintain hemoglobin. It may help patients by targeting lower bleeding during surgery.
This trial compares two surgical techniques to reduce bleeding during surgery to remove fibroids (benign tumors) from the uterus. The goal is to find the safest, least-bloody approach for women who need this procedure.
This trial tests whether temporarily clamping the main blood vessels to the uterus during laparoscopic fibroid removal can reduce blood loss. It is for women with up to four fibroids who are planning this type of surgery.
This study tests if blocking blood flow to the uterus and ovaries during minimally invasive fibroid removal surgery helps reduce bleeding. It may be an option if you are having this type of surgery for large or numerous fibroids.
Hear when a new Blood Loss, Surgical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.